Metabolite Alterations and Cardiometabolic Disease: A Nutritional Perspective
Författare
Summary, in English
Background
Cardiovascular
disease (CVD), type 2 diabetes (T2DM), and atrial fibrillation (AF)
collectively impact millions globally, necessitating a comprehensive
understanding of preceding metabolic alterations for early intervention. This
thesis aims to explore metabolic shifts across populations-based cohorts and
evaluate the metabolic impact of a dietary intervention.
Method
Utilizing
liquid-chromatography mass spectrometry, we quantified approximately 110
metabolites in over 6000 subjects from the Malmö Preventive Project (MPP),
Malmö Diet and Cancer (MDC), Malmö Offspring Study (MOS), and the Cilento
dietary intervention study (CDI). Paper I investigates associations between
metabolites and future atrial fibrillation in MDC. Paper II examines
associations between metabolites and a healthy dietary pattern in MDC, and
their associations with future CVD, T2DM, and mortality. Paper III presents a
metabolite-based model for healthy dietary intake assessed in MOS, testing its
association with future T2DM and CVD in MDC and MPP. Paper IV assesses the
metabolic effects of a 6-day Mediterranean diet intervention among Swedish
participants in the CDI.
Results
Paper I
identifies 15 metabolites with significant associations with AF, particularly
acylcarnitines (1). Paper II associates six
metabolites with healthy dietary intake, with ergothioneine especially
inversely related to CVD and overall mortality (2). Paper III's metabolic signature
for healthy dietary intake associates with lower T2DM and CVD incidence in both
MPP and MDC (3). Paper IV reports significant
post-intervention metabolite changes, especially in the dietary related
metabolome.
Discussion
This
thesis provides a comprehensive analysis of metabolite alterations associated
with CVD, T2DM, and AF, elucidating the relationships between metabolic and
dietary pattern biomarkers and disease risk. The findings emphasize the utility
of plasma metabolites as potential predictors and intermediaries in the pathways
leading to these major diseases. Paper 3 and 4 combined acts as a proof of
concept that plasma metabolites can be used to identify subgroups with higher
risk for CVD and T2DM that might be caused by poor dietary intake Similar
methods could be used to develop validated metabolic analyses as biomarkers for
healthy dietary intake, with potential application in personalized preventive
medicine.
Publiceringsår
2024
Språk
Engelska
Publikation/Tidskrift/Serie
Lund University, Faculty of Medicine Doctoral Dissertation Series
Issue
2024:57
Fulltext
Dokumenttyp
Doktorsavhandling
Förlag
Lund University, Faculty of Medicine
Ämne
- Endocrinology and Diabetes
Nyckelord
- Metabolomics
- Nutrition
- Nutritional metabolomics
- Biomarkers
- Cardiometabolic disease
- Cardiovascular disease
- Type 2 diabetes
- Prospective cohort studies
- Dietary intervention
Status
Published
Forskningsgrupp
- Cardiovascular Research - Hypertension
ISBN/ISSN/Övrigt
- ISSN: 1652-8220
- ISBN: 978-91-8021-550-3
Försvarsdatum
8 maj 2024
Försvarstid
09:00
Försvarsplats
Aulan, CRC, Jan Waldenströms gata 35, Skånes Universitetssjukhus i Malmö
Opponent
- Rikard Landberg (professor)